These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18771565)

  • 1. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients.
    Kavanagh-Wright L; Smith TP; Gibney J; McKenna TJ
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):599-605. PubMed ID: 18771565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid detection of macroprolactin in the form of prolactin-immunoglobulin G complexes by immunoprecipitation with anti-human IgG-agarose.
    Schiettecatte J; De Schepper J; Velkeniers B; Smitz J; Van Steirteghem A
    Clin Chem Lab Med; 2001 Dec; 39(12):1244-8. PubMed ID: 11798085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should macroprolactin be measured in all hyperprolactinaemic sera?
    McKenna TJ
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroprolactin; high molecular mass forms of circulating prolactin.
    Fahie-Wilson MN; John R; Ellis AR
    Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins.
    Ram S; Harris B; Fernando JJ; Gama R; Fahie-Wilson M
    Ann Clin Biochem; 2008 May; 45(Pt 3):256-9. PubMed ID: 18482912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
    Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
    Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of prolactin: the macroprolactin problem.
    Fahie-Wilson M; Smith TP
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.
    Smith TP; Suliman AM; Fahie-Wilson MN; McKenna TJ
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5410-5. PubMed ID: 12466327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of macroprolactin in a patient with asymptomatic hyperprolactinemia as a stable PRL-IgG complex.
    Bonhoff A; Vuille JC; Gomez F; Gellersen B
    Exp Clin Endocrinol Diabetes; 1995; 103(4):252-5. PubMed ID: 7584531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up.
    Hattori N; Ishihara T; Saiki Y; Shimatsu A
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):792-7. PubMed ID: 20874771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroprolactin, big-prolactin and potential effects on the misdiagnosis of hyperprolactinemia using the Beckman Coulter Access Prolactin assay.
    Ellis MJ; Livesey JH; Soule SG
    Clin Biochem; 2006 Oct; 39(10):1028-34. PubMed ID: 16919253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroprolactinemia: diagnostic, clinical, and pathogenic significance.
    Shimatsu A; Hattori N
    Clin Dev Immunol; 2012; 2012():167132. PubMed ID: 23304187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection of macroprolactin by precipitation and ultrafiltration methods.
    Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
    Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia.
    Hattori N; Nakayama Y; Kitagawa K; Ishihara T; Saiki Y; Inagaki C
    J Endocrinol; 2006 Aug; 190(2):287-93. PubMed ID: 16899562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of macroprolactinaemia.
    Hattori N; Adachi T; Ishihara T; Shimatsu A
    Eur J Endocrinol; 2012 Apr; 166(4):625-9. PubMed ID: 22247016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
    Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol.
    Fahie-Wilson M; Bieglmayer C; Kratzsch J; Nusbaumer C; Roth HJ; Zaninotto M; Plebani M; Hubbuch A; Schneider E
    Clin Lab; 2007; 53(5-6):301-7. PubMed ID: 17605405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.